trial

Cognitive Remediation Program for Hospitalized in the Long Term Patients With Deficit Schizophrenia

NCTId NCT03407950
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Withdrawn
Enrollment 0 (actual)
Sponsored by University Hospital, Montpellier
Primary completion 2020-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Withdrawn
Enrollment
0 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2018-01
Primary completion
2020-12
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
IPT+

Sponsors

University Hospital, MontpellierLead Sponsor

Investigators

1
Delphine CAPDEVIELLE, PU-PHPrincipal Investigator

Sites

1 total
Montpellier, France

Facts & assertions

4 sourced
Enrollment
0
Phase
NA
Primary Completion Date
2020-12
Status
WITHDRAWN
relationships
The graph out of here
drug
IPT+
drug
lead_sponsor
University Hospital, Montpellier
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Delphine CAPDEVIELLE, PU-PH
person